Dislocated Intraocular Lens Clinical Trial
— VISIAOfficial title:
Vitreous Surgery With Intraocular Assistance (VISIA)
| Verified date | September 2017 |
| Source | Johns Hopkins University |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Interventional |
To Assess the Safety of Vitreous surgery with intraocular assistance (VISIA) & to identify and document with video evidence and surgeon's case report forms intraocular maneuvers that are facilitated by VISIA.
| Status | Terminated |
| Enrollment | 5 |
| Est. completion date | September 2017 |
| Est. primary completion date | September 2017 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | 18 Years to 100 Years |
| Eligibility |
Inclusion Criteria: All subjects must meet the following criteria to be eligible for study entry: - Signed informed consent and authorization of use and disclosure of protected health information - Age =18 years - Subject will have complex retinal pathology for which it is judged that surgical objectives could be facilitated by VISIA Exclusion Criteria: Subjects who meet any of the following criteria will be ineligible for study entry: • Patients with disease processes such as macular pucker and macular hole that are generally well-managed by standard two-handed vitrectomy. |
| Country | Name | City | State |
|---|---|---|---|
| United States | Wilmer Eye Institute, Johns Hopkins University School of Medicine | Baltimore | Maryland |
| Lead Sponsor | Collaborator |
|---|---|
| Johns Hopkins University |
United States,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | The primary outcome measure is recording of adverse events directly related to VISIA and adverse events unrelated to VISIA. | 4 months | ||
| Secondary | Surgeon's assessment of the benefits and risks of VISIA recorded on the surgical case report form. | 4 months | ||
| Secondary | Assistant's assessment of the benefits and risks of VISIA recorded on the surgical case report form. | 4 months |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT06347302 -
Study of Vitreoretinal Molecular Changes During Rhegmatogenous Retinal Detachment
|
N/A |